Product Information
CLOMIPRAMINE 25 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.1774 per EA under NDC 69315016701. Its NADAC has been published 303 times since Nov 4, 2020.
FDA first approved this application on Feb 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Clomipramine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211364FDA Approved
2/7/2020
TE Code
AB
On Market Since
3/10/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 25 MG CAPSULE has been published 303 times since Nov 4, 2020, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1774 per EA |
|---|---|
| All-time high | $2.9208 (Jan 13, 2021) |
| All-time low | $0.1694 (Jul 22, 2026) |
| 52-week high | $0.2669 |
| 52-week low | $0.1694 |
| Median price | $0.3353 |
| Average price | $0.6962 |
| Largest weekly change | +59.2% (May 19, 2021) |
| Weeks tracked | 303 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 25 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.1774 per EA (NDC 69315016701), effective Aug 19, 2026.
How has the price of CLOMIPRAMINE 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 25 MG CAPSULE has declined 93.1%. It has been tracked across 303 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 25 MG CAPSULE?
Since Nov 4, 2020, the NADAC for CLOMIPRAMINE 25 MG CAPSULE has ranged from a low of $0.1694 (Jul 22, 2026) to a high of $2.9208 (Jan 13, 2021), with a median of $0.3353 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 25 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 25 MG CAPSULE?
CLOMIPRAMINE 25 MG CAPSULE (NDC 69315016701) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.